SHC
Sotera Health Co Health Care Services-Misc Health & Allied Services, NEC Russell 3000
$18.15Close
$5.2BMarket cap
$13.13 – $19.5752-week range
Nov 3, 2026Next report · before the open
Highlights
Strengths
- Earnings growing EPS +568% year on year
Cautions
- Trend not confirmed 6 of 8 conditions · under the 50-day, RS under 70
- Results soon Nov 3, 2026, in 2 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
7%
1wk
up 0.3%
price change
1mo
down 1.8%
price change
12-month return
up 11%
market up 11% ·
its own down 1%
F-score
8 / 9
Exceptional
Altman Z″
0.74
Elevated risk
P/E
66.6×
price / earnings
PEG
0.89
P/E / EPS growth
P/B
8.6×
price / book
Earnings yield
up 2.1%
EBIT / enterprise value
Cheaper than
34%
of the market · expensive
Revenue growth
up 6%
year on year
EPS growth
up 568%
latest quarter
Sales growth
up 9%
latest quarter · -1 pts
ROE
up 15%
return on equity
Free cash margin
up 13%
$149.2M FCF
D/E
3.51
long-term debt / equity
Net debt / EBITDA
7.4×
Interest cover
—EBIT / interest
Piotroski tests
- short-term liquidity weakened
- profitable on its assets
- generating cash from operations
- profitability improving
- profits backed by cash
- reduced long-term debt
- no new shares issued
- gross margin widened
- assets working harder
Trade setup
ATR%
2.8%
$0.50 a day · 2×ATR $17.15
RS
54 / 99
vs the universe
Trend
6 / 8
under the 50-day, RS under 70
Relative volume
1.7×
vs 50-day average
Up/down volume
0.88
50 sessions
Implied move
—
no option chain · report Nov 3, 2026
Trend template · 6 of 8
- Price above the 50-day average: fails
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Heavily indebted Net debt is 7.4 times EBITDA — roughly 7 years of earnings before interest, tax and depreciation to repay borrowings in full.
Last reported
Aug 6, 2026
Results reaction
Aug 6, 2026+4% vs market2 sessions after results
Financials
- Gross 55%
- Net 7%
- Free cash 13%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $818.2M | $931.5M | $1.0B | $1.0B | $1.1B | $1.2B |
| Gross margin | 54% | 56% | 55% | 55% | 55% | 55% |
| Operating income | $206.0M | $256.7M | $248.3M | $276.7M | $297.6M | — |
| Net income | -$38.6M | $116.2M | -$233.6M | $51.4M | $44.4M | $77.9M |
| Net margin | -5% | 12% | -23% | 5% | 4% | 7% |
| Earnings per share | -$0.16 | $0.42 | -$0.83 | $0.18 | $0.16 | $0.27 |
| Free cash flow | $67.1M | $179.4M | $95.6M | -$362.7M | $45.1M | $149.2M |
| Free cash margin | 8% | 19% | 10% | -35% | 4% | 13% |
| Cash | $102.4M | $106.9M | $395.2M | $296.4M | $277.2M | $344.6M |
| Long-term debt | $1.8B | $1.7B | $1.7B | $2.2B | $2.2B | $2.1B |
| Shareholders' equity | $452.3M | $586.1M | $350.2M | $443.7M | $404.9M | $606.0M |
| Shares outstanding | 285.99m | 286.04m | 286.04m | 286.04m | 286.04m | 286.04m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 6, 2026 | Quarterly ↗ | Jun 30, 2026 | 37d |
| May 5, 2026 | Quarterly ↗ | Mar 31, 2026 | 35d |
| Feb 24, 2026 | Annual ↗ | Dec 31, 2025 | 55d |
| Nov 4, 2025 | Quarterly ↗ | Sep 30, 2025 | 35d |
| Aug 8, 2025 | Quarterly ↗ | Jun 30, 2025 | 39d |
| May 1, 2025 | Quarterly ↗ | Mar 31, 2025 | 31d |
| Feb 27, 2025 | Annual ↗ | Dec 31, 2024 | 58d |
| Nov 5, 2024 | Quarterly ↗ | Sep 30, 2024 | 36d |
| Aug 5, 2024 | Quarterly ↗ | Jun 30, 2024 | 36d |
| May 2, 2024 | Quarterly ↗ | Mar 31, 2024 | 32d |
| Feb 27, 2024 | Annual ↗ | Dec 31, 2023 | 58d |
| Nov 1, 2023 | Quarterly ↗ | Sep 30, 2023 | 32d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 14, 2026 | Director or officer change ↗ |
| Aug 6, 2026 | Results ↗ |
| May 22, 2026 | Shareholder vote ↗ |
| May 20, 2026 | Material agreement · New obligation ↗ |
| May 13, 2026 | Agreement ended · Other events ↗ |
| May 5, 2026 | Results · Director or officer change ↗ |
| Mar 16, 2026 | Director or officer change ↗ |
| Mar 6, 2026 | Other events ↗ |
| Feb 24, 2026 | Results · Director or officer change ↗ |
| Feb 5, 2026 | Director or officer change ↗ |
| Jan 12, 2026 | Results · Regulation FD ↗ |
| Nov 10, 2025 | Other events ↗ |